POPLAR POINT CAPITAL PARTNERS LP
SEC insider (Form 3/4/5 filer). CIK 0001588289. 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY). 36 reported Form 4/5 transactions since Sep 2024; latest on Apr 8, 2025. Located in BURLINGAME, CA.
Companies POPLAR POINT CAPITAL PARTNERS LP has filed insider reports for
- NovaBay Pharmaceuticals, Inc. (NBY): 10% Owner
POPLAR POINT CAPITAL PARTNERS LP
CIK: 0001588289
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NovaBay Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Apr 8, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect300 shares at avg. $0.47$139.5 - Apr 4, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect4.5K shares at avg. $0.52$2K - Apr 3, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect23K shares at avg. $0.56$13K - Apr 2, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect917 shares at avg. $0.58$531.86 - Apr 1, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect19.9K shares at avg. $0.58$12K - Mar 31, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect21.7K shares at avg. $0.59$13K - Mar 28, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect49.4K shares at avg. $0.61$30K - Mar 27, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect600 shares at avg. $0.61$365.4 - Mar 27, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect18.5K shares at avg. $0.61$11K - Mar 26, 2025NBY
NovaBay Pharmaceuticals, Inc.
PurchaseDirect13.3K shares at avg. $0.61$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 8, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 300 | $0.47 | $140 | Direct |
| Apr 4, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 4,538 | $0.52 | $2,367 | Direct |
| Apr 3, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 22,976 | $0.56 | $12,929 | Direct |
| Apr 2, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 917 | $0.58 | $532 | Direct |
| Apr 1, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 19,915 | $0.58 | $11,650 | Direct |
| Mar 31, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 21,654 | $0.59 | $12,776 | Direct |
| Mar 28, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 49,400 | $0.61 | $30,253 | Direct |
| Mar 27, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 600 | $0.61 | $365 | Direct |
| Mar 27, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 18,504 | $0.61 | $11,380 | Direct |
| Mar 26, 2025 | NBY NovaBay Pharmaceuticals, Inc. | Purchase | 13,292 | $0.61 | $8,095 | Direct |
1-10 of 36 transactions